AZIDE SUGCON DIABETRON DB-ZIDE DIAMIDE DIAGLIC GETZID MR GETZID MR SUCRONIL GLYNASE DIOCID MACAZID GLAZE GLARE TAB GLICOTRON PROZIDE NIDONIL PROTECT DIAMICRON-MR DIAMICRON GLICOZID TAGAMICRON NODIBET NODIBET ZACLAZIDE DICLAZIDE GLICLAZIDE LOWGLUCO GLIMICRON GLIMICRON GLIZID-80 DIABO GLICALA GLICLAZ GLICAZ TRYMICRON MR FYMICRON GLIDE ZENZIDE GLUCOSIDE-MR VZIDE GLICLAMED SCICON MR SCICON MR GLINEXT GLIMIN FORTE APTIZID

Dose: 40 to 80 mg
Single Dose: 60 (60)
Frequency: 24 hourly
Route: PO
Instructions: Max dose 320 mg. doses > 160 mg given in 2 divided doses.

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

Gliclazide also known as Glicazida. . It is of Synthetic origin and belongs to Sulphonyl Urea. It belongs to Potassium Channel (ATP sensitive) antagonist pharmacological group on the basis of mechanism of action and also classified in Antidiabetic Agent, Sulfonylurea pharmacological group.The Molecular Weight of Gliclazide is 323.40. Its pKa is 5.8.

Gliclazide is contraindicated in conditions like Iddm,Ketosis.

The severe or irreversible adverse effects of Gliclazide, which give rise to further complications include GI symptoms, Dermatological reactions, Hypoglycemia.Gliclazide produces potentially life-threatening effects which include Hypoglycemia, Hypoglycemia, Hypoglycemia, Brain damage. which are responsible for the discontinuation of Gliclazide therapy.The signs and symptoms that are produced after the acute overdosage of Gliclazide include Hypoglycemia, Cerebral edema.The symptomatic adverse reactions produced by Gliclazide are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Nausea, Skin rashes, GI upset, Skin rashes, dizziness.

Gliclazide is primarily indicated in conditions like Diabetes mellitus type-ii.

Gliclazide is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAlcoholAspirinClofibrateDiazoxidePhenylbutazone RifampicinSulphamethizoleGliclazide may be displaced from protein binding sites or their metabolism may be inhibited by some sulfonamides, resulting in increased or prolonged effects or toxicity.Dosage adjustments may be necessary during and after sulfonamide therapy These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Liver Malfunction, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab Store in a well closed container, Below 40°C. Protect from Sunlight.

Should not be used in severe renal imparement